(3R,6S,7aS)-6-bromo-3-phenyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one

Catalog No. :
ACGRNI465
CAS No. :
176484-88-1
Molecular Formula :
C12H12BrNO2
Molecular Weight :
282.14

IUPAC Name:(3S,6S,7aS)-6-bromo-3-phenyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one

(3R,6S,7aS)-6-bromo-3-phenyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$648.00Login to see priceInquiryInquiry
1g95%$1624.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,6S,7aS)-6-bromo-3-phenyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one
IUPAC Name(3S,6S,7aS)-6-bromo-3-phenyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one
Molecular FormulaC12H12BrNO2
Molecular Weight282.14
SMILESO=C1[C@@H](Br)C[C@H]2CO[C@@H](C3=CC=CC=C3)N12
InChI KeyUHAUKCUMZSWGEC-NHCYSSNCSA-N
Synonym(3R,6S,7aS)-6-bromo-3-phenyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one(WX116150);(3R,6S,7aS)-6-bromo-3-phenyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one;(3R,6S,7aS)-6-Bromo-3-phenyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one;3H,5H-Pyrrolo[1,2-c]oxazol-5-one, 6-bromotetrahydro-3-phenyl-, [3R-(3α,6β,7aα)]- (9CI)
CAS No.176484-88-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGRNI465 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGRNI465 route product structure diagram
    ACGRNI465176484-88-1
Inquiry

2. ACGRNI465 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGRNI465 route product structure diagram
    ACGRNI465176484-88-1
Inquiry

Comments (0)